Folic Acid and Vitamin B12 Administration in CKD, Why Not?

Folic Acid and Vitamin B12 Administration in CKD, Why Not?

Patients affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD) experience a huge cardiovascular risk and cardiovascular events represent the leading causes of death. Since traditional risk factors cannot fully explain such increased cardiovascular risk, interest in non-tradition...

Full description

Bibliographic Details
Main Authors: Irene Capelli, Giuseppe Cianciolo, Lorenzo Gasperoni, Fulvia Zappulo, Francesco Tondolo, Maria Cappuccilli, Gaetano La Manna
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Nutrients
Subjects:
cardiovascular disease
chronic kidney disease
end-stage renal disease
hyperhomocysteinemia
folic acid
vitamin B12
Online Access:https://www.mdpi.com/2072-6643/11/2/383

Similar Items

Similar Items